Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen

People who receive the ChAdOx1 nCoV-19 vaccine, particularly perimenopausal women who are on birth control or postmenopausal women who take estrogen supplements, may experience thrombosis and thrombocytopenia. Estrogen and the ChAdOx1 nCoV-19 vaccine both have the potential to cause thrombus in diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Soltani Hekmat, Ava, Javanmardi, Kazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560237/
https://www.ncbi.nlm.nih.gov/pubmed/34734086
http://dx.doi.org/10.1155/2021/7702863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560237/
https://www.ncbi.nlm.nih.gov/pubmed/34734086
http://dx.doi.org/10.1155/2021/7702863

Ejemplares similares